Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating an access restriction that prevents viewing the study details.SummaryDifference20%

- Check40 days agoChange Detected- The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a version update to the page; no user-facing study content appears to have changed.SummaryDifference0.0%

- Check47 days agoChange DetectedCertification/Extension metadata was added and two study documents—Study Protocol (11.15 MB) and Statistical Analysis Plan (3.4 MB)—were added to the Study Documents, while older entries from 2026 May–June were removed.SummaryDifference1%

- Check54 days agoChange DetectedThe study record revision was updated to v3.6.6 from v3.6.5, indicating a recent metadata update to the page. The update does not alter the study content or user-visible details.SummaryDifference0.1%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.